MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
DRUG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Bright Minds Biosciences (DRUG) Ownership - Who owns Bright Minds Biosciences?

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
19 Vestry Street
Phone
+1 647 865-8622
Employees
1
Web
https://www.brightmindsbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
618.35M
P/E Ratio
N/A
Total Cash
309.69M
Projected Growth
N/A
Total Debt
82.13K
Revenue
N/A
Risk (Beta)
-19.27
Dividend Yield
N/A
Total Cash/Share
31.56
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
DRUG
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for DRUG
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
19 Vestry Street
Phone
+1 647 865-8622
Employees
1
Web
https://www.brightmindsbio.com